Study of Oral Palifosfamide Tris in Solid Tumors
NCT00607711
·
clinicaltrials.gov ↗
PHASE1
Phase
SUSPENDED
Status
20
Enrollment
INDUSTRY
Sponsor class
Stopped
IND was withdrawn
Conditions
Advanced Cancer
Interventions
DRUG:
oral palifosfamide tris
Sponsor
Alaunos Therapeutics